Lymphoma, Immunodeficiency and the Epstein-Barr Virus
- 17 November 1977
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 297 (20) , 1120-1121
- https://doi.org/10.1056/nejm197711172972010
Abstract
It is established that Epstein–Barr virus (EBV) is the etiologic agent of infectious mononucleosis and African Burkitt's lymphoma. Thus, EBV, a herpes-related virus, commonly causes a benign, self-limited infection in man, or, in certain settings, a malignant lymphoma.1 EBV infects primarily, if not exclusively, the B lymphocytes of man and subhuman primates.2 When B lymphocytes are infected in vivo by EBV, the infected B cells are attacked and destroyed by T lymphocytes. This war among the lymphocytes is manifested clinically as infectious mononucleosis. In vitro B lymphocytes infected with EBV become immortal in that long-term B-lymphocyte culture lines can be . . .Keywords
This publication has 4 references indexed in Scilit:
- Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes.The Journal of Experimental Medicine, 1977
- The Epstein-Barr Virus and NeoplasiaNew England Journal of Medicine, 1975
- Restriction of in vitro T cell-mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semiallogeneic systemNature, 1974
- SURFACE MARKERS ON HUMAN B AND T LYMPHOCYTESThe Journal of Experimental Medicine, 1973